ProfileGDS4132 / 207361_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 44% 54% 31% 26% 44% 47% 36% 47% 25% 35% 27% 25% 25% 24% 16% 19% 32% 29% 26% 28% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 101116.69944
GSM201543Muscle PCOS pioglitazone 121139.85854
GSM201544Muscle PCOS pioglitazone 16178.516731
GSM201545Muscle PCOS pioglitazone 20167.897226
GSM201829Muscle PCOS pioglitazone 231121.58844
GSM201830Muscle PCOS pioglitazon 251128.40247
GSM201831Muscle PCOS pioglitazone 27191.239636
GSM201832Muscle PCOS pioglitazone 31123.82147
GSM201833Muscle PCOS pioglitazone 4156.464125
GSM201834Muscle PCOS pioglitazone 8185.764435
GSM201835Muscle PCOS after pioglitazone 10251.786527
GSM201836Muscle PCOS after pioglitazone 12248.59725
GSM201837Muscle PCOS after pioglitazone 16247.772625
GSM201838Muscle PCOS after pioglitazone 20249.288724
GSM201839Muscle PCOS after pioglitazone 23229.703816
GSM201840Muscle PCOS after pioglitazone 25239.998619
GSM201841Muscle PCOS after pioglitazone 27264.151332
GSM201842Muscle PCOS after pioglitazone 3255.5729
GSM201843Muscle PCOS after pioglitazone 4260.380726
GSM201844Muscle PCOS after pioglitazone 8262.328